Biotech Exit: Million Arcellx Sparks Investor Reassessment
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Investors follow market indices to gauge performance, set expectations, and benchmark risk. Indices provide a common frame for evaluating results.
28,426 articlesA notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
SoFi stock fell last month, sparking questions about the growth story and valuation. This article breaks down the fac...
SpaceX finally opened its doors to public markets, signaling a pivotal moment for growth investors. This guide breaks...
Tech stocks swung wildly midday as traders dumped riskier names, then rotated into consumer staples and paints. By da...
Institutional traders are piling into XRP spot buying while the futures market cools, signaling a pivot in market par...
When stocks wobble, redirecting payouts to safer assets can cushion the blow. This article explains how dividends rei...
Investing in builders requires more than chasing growth. This deep dive unpacks why dream finders homes: promising st...
A surprise leadership change jolted Copart’s stock, sparking an intraday drop. This article breaks down the why, what...
Rivian shares surged about 8% after the company unveiled the R2 midsize SUV, signaling a push toward broader market a...
A recently launched XRP-focused ETF aims to deliver 3% monthly income by selling XRP call options, blending crypto ex...
The trillion-dollar club has swelled to 14 as of late May 2026, led by AI-enabled tech giants. The combined market ca...
Rivian unveiled a new entry SUV meant to broaden its addressable market, but the stock slid as investors question whe...